<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Miles KG</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>Jayden DeLuca Foundation</funding><funding>College of Medicine, University of Cincinnati</funding><funding>NCATS NIH HHS</funding><funding>Cincinnati Children&amp;apos;s Hospital Medical Center</funding><funding>National Institutes of Health</funding><pagination>101962</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12702102</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Impaired right atrial (RA) function is strongly predictive of adverse outcomes in adults with pulmonary arterial hypertension (PAH) but remains incompletely understood in pediatric PAH. In this pediatric multi-center retrospective cohort study using cardiovascular magnetic resonance imaging (CMR), we analyzed RA size and phasic function and its associations with PAH severity.&lt;h4>Methods&lt;/h4>PAH and control pediatric patients from two centers who underwent CMR from 2010 to 2023 were identified. RA volumes were measured throughout the cardiac cycle using the single-plane, area-length method on a standard 4-chamber cine sequence. Total, conduit phase, and active phase stroke volume (SVi; indexed to BSA) and ejection fraction (EF) were calculated. A novel marker, the A/C rat</pubmed_abstract><journal>Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance</journal><pubmed_title>Right Atrial Function is Impaired in Pediatric Pulmonary Arterial Hypertension: A Multi-center Cardiovascular Magnetic Resonance Study.</pubmed_title><pmcid>PMC12702102</pmcid><funding_grant_id>UL1 TR002535</funding_grant_id><pubmed_authors>Cash M</pubmed_authors><pubmed_authors>Frank BS</pubmed_authors><pubmed_authors>Miles KG</pubmed_authors><pubmed_authors>Ollberding NJ</pubmed_authors><pubmed_authors>Luebbe K</pubmed_authors><pubmed_authors>Lang SM</pubmed_authors><pubmed_authors>Ta HT</pubmed_authors><pubmed_authors>Magness M</pubmed_authors><pubmed_authors>O'Neil M</pubmed_authors><pubmed_authors>Critser PJ</pubmed_authors><pubmed_authors>Hirsch R</pubmed_authors><pubmed_authors>Bjorkman KR</pubmed_authors><pubmed_authors>Gao Z</pubmed_authors><pubmed_authors>Ivy DD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Right Atrial Function is Impaired in Pediatric Pulmonary Arterial Hypertension: A Multi-center Cardiovascular Magnetic Resonance Study.</name><description>&lt;h4>Background&lt;/h4>Impaired right atrial (RA) function is strongly predictive of adverse outcomes in adults with pulmonary arterial hypertension (PAH) but remains incompletely understood in pediatric PAH. In this pediatric multi-center retrospective cohort study using cardiovascular magnetic resonance imaging (CMR), we analyzed RA size and phasic function and its associations with PAH severity.&lt;h4>Methods&lt;/h4>PAH and control pediatric patients from two centers who underwent CMR from 2010 to 2023 were identified. RA volumes were measured throughout the cardiac cycle using the single-plane, area-length method on a standard 4-chamber cine sequence. Total, conduit phase, and active phase stroke volume (SVi; indexed to BSA) and ejection fraction (EF) were calculated. A novel marker, the A/C rat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-06T03:46:07.09Z</modification><creation>2026-05-25T03:11:25.638Z</creation></dates><accession>S-EPMC12702102</accession><cross_references><pubmed>40976452</pubmed><doi>10.1016/j.jocmr.2025.101962</doi></cross_references></HashMap>